Neutrophil gelatinase-associated lipocalin: A novel biomarker in acute kidney injury

Cirugia y Cirujanos

Volumn 79, Issue 6, 2011, Pages 530-534

  Carrillo Esper, Raúl ^a   Castillo Albarrán, Fátima Martha ^b   Pérez Jáuregui, José ^b  

^a Servicio de Terapia Intensiva   (Mexico)

^b LIVER RESEARCH UNIT   (Mexico)

Author keywords

Acute kidney injury; Biomarkers; Lipocalin

Indexed keywords

EID: 83755205849     PISSN: 00097411     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bagshaw SM, George C, Bellomo R. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 2008;12:1-9.
2. Rodríguez LM, Roglan PA. Diagnóstico precoz del fracaso renal agudo. Med Intensiva 2010;34:291-293.
3. Alcázar R, De la Torre M, Santana H. Avances en la insuficiencia renal aguda en el año 2008. Nefrologia 2009;29:82-87.
4. Kümpers P, Hafer C, Lukasz A, Lichtinghagen R, Brand K, Fliser D, et al. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care 2010;14:1-9.
5. García GA. Reproducción y fertilidad humana: aspectos biomédicos de la familia de las lipocalinas. Repert Med Cir 2009;18:5-20.
6. García GA, Clavijo D, Mejía OR, García A, Vittorino M, Casadiego CA, et al. Aspectos biomédicos de la familia de las lipocalinas. Universitas Medica 2007;48:118-128.
7. Flower DR. The lipocalin protein family: structure and function. Biochem J 1996;318:1-14. (Pubitemid 26283618)
8. Flo TH, Smith KD, Sato S, Rodríguez DJ, Holmes MA, Strong RK, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004;432:917-921. (Pubitemid 40037155)
9. Yang J, Mori K, Li JY, Barach J. Iron, lipocalin, and kidney epithelia. Am J Physiol 2003;285:9-18.
10. Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J 2010;31:703-711.
11. Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl 2008;241:89-94. (Pubitemid 351883665)
12. Wheeler D, Devarajan P, Qing M, Harmon K, Monaco M, Cvijanovich N, et al. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 2008;36:1297-1303. (Pubitemid 351482681)
13. Devarajan P. NGAL in acute kidney injury: from serendipity to utility. Am J Kidney Dis 2008;52:395-399.
14. Zappitelli M, Washburn K, Arikan A, Loftis L, Qing M, Devarajan P. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 2007;11:1-11.
15. Mitsnefes M, Kathman T, Mishra J, Kartal J, Khoury PR, Nickolas T. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 2007;22:101-108. (Pubitemid 46138368)
16. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio M, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009;4:337-344.
17. Xu SY, Pauksen K, Venge P. Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest 1995;55:125-131.
18. Bagshaw S, Bennett M, Haase-Fielitz M, Haase A, Egi M, Morimatsu H. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med 2010;36:452-461.
19. Bohjörkqvist M, Kallman J, Fjaertoft G, Venge P, Schollin J. Human neutrophil lipocalin: normal levels and use as a marker for invasive infection in the newborn. Acta Pediatr 2004;4:534-539. (Pubitemid 38469703)